Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Ragusa

5 clinical trials in Ragusa, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Ragusa at a glance
5
clinical trials
  • Not yet recruiting0
  • Paediatric trials0
  • Research sites0
Type of trial
Recruitment status
Quick filters

5 trials in Ragusa

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Avelumab
  • Sponsor:Gruppo Oncologico Dell'Italia Meridionale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Panitumumab
  • Sponsor:IRCCS Istituto Nazionale Tumori Fondazione Pascale
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Acetylsalicylic Acid
  • Sponsor:SORIN CRM SAS (Microport CRM)
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Bevacizumab
  • Sponsor:Gruppo Oncologico Dell'Italia Meridionale

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Ragusa

What the registry says about research in the country

01 Colorectal Cancer Research

Innovative studies focusing on metastatic colorectal cancer treatments, exploring combination therapies and biomarker-driven approaches. Research includes evaluation of novel drug combinations and treatment strategies for patients with specific genetic profiles.

  • RAS/BRAF wild-type treatments
  • Combination therapy effectiveness
  • Biomarker-driven protocols

Multiple trials are investigating continuous versus intermittent treatment approaches to optimize patient outcomes.

02 Rectal Cancer Interventions

Research examining neoadjuvant therapy approaches for locally advanced rectal cancer, incorporating common medications in new therapeutic contexts. Studies are evaluating the impact on tumor response and patient outcomes.

  • Preoperative chemotherapy optimization
  • Drug repurposing studies
  • Pathological response assessment

Trials combine standard treatments with novel therapeutic approaches to enhance treatment effectiveness.

03 Cardiovascular Studies

Critical research in acute myocardial infarction and cardiac interventions, including studies on modified anti-platelet therapies and treatments for atrial fibrillation. Investigations focus on improving outcomes for high-risk cardiac patients.

  • Drug-eluting stent protocols
  • Anti-platelet therapy optimization
  • Stroke prevention strategies

Innovative approaches are being tested to enhance patient safety and treatment efficacy in cardiac conditions.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.